Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Monday’s trading has closed, but REGN is being traded in the after-hours session. After-Hours quote »
459.78
Delayed Data
As of 4:00pm ET
 +5.28 / +1.16%
Today’s Change
269.50
Today|||52-Week Range
495.50
+12.07%
Year-to-Date

Today’s Trading

Previous close454.50
Today’s open459.05
Day’s range453.11 - 462.59
Volume640,941
Average volume (3 months)889,773
Market cap$46.6B
Dividend yield--
Data as of 4:00pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.20%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio149.8
Price/Sales14.64
Price/Book18.31

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+3.72+3.57%
QQuintiles Transnatio...+0.74+1.10%
ISISIsis Pharmaceuticals...+1.44+2.27%
ICLRICON PLC+0.47+0.67%
Data as of 4:02pm ET, 03/30/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.68
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account